CardioLogical Solutions is an emerging cardiovascular device company formed by the merger of Emboline and VasoStitch and its breakthrough platform of accessory devices for transcatheter aortic valve replacement (TAVR) procedures.

 

Biosense Webster showcased its portfolio of cutting edge innovative electrophysiology technologies at the 2013 Boston AF meeting.

 

 

In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD Application, available for the iPhone and iPad to ensure that 100 percent of patients screened meet the evidence-based criteria for implantation.

TeraRecon received the North American New Product Innovation Award in Medical Imaging Informatics from the respected independent research firm Frost and Sullivan. This is the seventh time that TeraRecon Inc. has been recognized with a Best Practices award from Frost and Sullivan, and the third time since 2010, following the European Company of the Year Award in the category of Medical Imaging, Advanced Visualization Applications, and the North American Growth Leadership of the Year Award.


Boston Scientific received CE mark approval for the Promus Premier everolimus-eluting platinum chromium coronary stent system, the company's next-generation durable polymer drug-eluting stent (DES) technology. The Promus Premier is designed to improve DES performance with a new delivery system and redesigned stent architecture that improves radial, axial strength and deliverability.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now